Aglan ABG is a medical diagnostic tool for healthcare professionals to monitor respiratory function and acid-base balance on iOS and Android.
The App DNA
What makes this app unique?
The application removes the manual calculation friction for clinicians assessing pO2, pCO2, and pH levels during patient care.
For Healthcare professionals requiring diagnostic tools for monitoring patient respiratory function and acid-base balance.
What does it look like?
Key features
Calculates oxygenation (pO2), carbon dioxide tension (pCO2), and pH levels for respiratory function assessment.
Tracks respiratory function changes over time to identify clinical trends.
How much does it cost?
The application is currently offered as a free tool with no observable in-app purchases or subscription tiers.
Velocity
Dormant developmentopaqueShow more...
Aglan ABG has been inactive for 341 days, falling well outside the threshold for active development. With only two releases in the observed history and no updates for nearly a year, the project shows no signs of ongoing maintenance or feature expansion. The development trend is stagnant, and the app is currently classified as a zombie.
Who built it?
Alpha Ralph
3 apps tracked · Medical
El Saidy - حلواني الصعيدي
Bekya Pay - بيكيا بايUser Sentiment
What do users think recently?
Recent user voice shows a thrilled sentiment. Users appreciate high accuracy and conclusive results provide users with reliable data output for their specific needs and the interface design allows for straightforward navigation and ease of use during daily tasks.
How are ratings & reviews evolving?
What users say, by theme
- High accuracy and conclusive results provide users with reliable data output for their specific needs
- The interface design allows for straightforward navigation and ease of use during daily tasks
2 of 2 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Aglan ABG
How's the Medical market?
Aglan ABG occupies a niche medical utility space with zero public ratings across both platforms. The lack of recent development activity (341 days since the last update) positions the tool as a legacy utility rather than an active competitor.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Aglan ABG
Where is it heading?
Users report: The medical diagnostic tool market increasingly favors applications with active, transparent update cycles that guarantee data accuracy. Aglan ABG remains exposed due to its stagnant release cadence, which will likely lead to further user churn as clinicians migrate to more actively maintained alternatives.
- The eleven-month development silence creates a perception of abandonment, which erodes the professional trust required for clinical diagnostic tools.
The SWOT
- Clinical-grade diagnostic output provides conclusive data for respiratory assessment
- Simplified workflow design reduces cognitive load during daily clinical tasks
- Integration of automated PDF report generation would address the lack of documentation features
Next best moves
Ship a stability-focused update because the current eleven-month dormancy signals abandonment to clinical users → restore professional trust
The counter-intuitive read
The lack of monetization is a liability in the medical category…
Read the full takeBottom line
Aglan ABG provides a functional diagnostic utility, but the lack of updates since late 2025 creates a trust deficit that prevents adoption in high-stakes clinical environments.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing, source
Report last updated